Desmoglein 2 (DSG2) binding proteins and uses therefor
US11248028B2 · kind B2 · utility
0Cited by
6References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 2, 2020 |
| Grant date | Feb 15, 2022 |
| Priority date | — |
| Expiry date | Mar 2, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides recombinant adenoviral compositions and methods for their use in treating disorders associated with epithelial tissues.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.